Erratum to 'Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial' [Eur Urol 2022]

Autor:	Martin Bögemann, Neal D. Shore, Matthew R. Smith, Teuvo L.J. Tammela, Albertas Ulys, Egils Vjaters, Sergey Polyakov, Mindaugas Jievaltas, Murilo Luz, Boris Alekseev, Thierry Lebret, Martin Schostak, Frank Verholen, Marie-Aude Le Berre, Shankar Srinivasan, Jorge Ortiz, Ateesha F. Mohamed, Toni Sarapohja, Karim Fizazi
Rok vydání:	2023
Předmět:	Urology
Zdroj:	European Urology. 83:e60
ISSN:	0302-2838
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2930ad9fc8e8c29f23af175a7111900a https://doi.org/10.1016/j.eururo.2022.11.018 Zobrazit plný text záznamu Full Text from ScienceDirect